The upgrade to Buy reflects a positive outlook on Sotera Health's stock, suggesting confidence in its future performance. However, the reduction in the price target indicates some caution regarding the stock's valuation or potential headwinds. Overall, this could lead to increased investor interest and potentially a short-term uptick in SHC's stock price, despite the lowered price target.